Urothelial Carcinoma

Managing mUC With Pembrolizumab, Radical Resection of Primary Tumor
Frontline treatment of metastatic urothelial carcinoma (mUC) changed with the introduction of combinations such as avelumab and pembrolizumab with chemotherapy and the antibody-drug conjugate enfortumab vedotin (EV). A multi-institutional case study conducted by Albert Jang, MD, and colleagues analyzed the outcomes of 4 patients with locally advanced or oligometastatic UC with complete response (CR) on imaging who underwent treatment with frontline pembrolizumab-based regimens followed by resection of the primary tumor. ...
Advertisement

Latest News

Advertisement

Urothelial Carcinoma Knowledge Hubs

Curated clinical content based on urothelial cancer types, therapies, and technologies

Advanced Urothelial Carcinoma
Advanced Urothelial Carcinoma

Conference Coverage

Advertisement
Advertisement
Latest News